Sensus Healthcare, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M |
| Gross profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M |
| Operating income | -$10.3M | $8.1M | -$382,000 | $14.8M | $4.1M |
| Operating expenses | $22.2M | $16.3M | $14.4M | $14.8M | $12.9M |
| Cost of revenue | $15.6M | $17.4M | $10.3M | $14.9M | $10.1M |
| Cash from operations | $528,000 | -$831,000 | -$2.1M | -$1.4M | -$286,000 |
| Capital expenditure | $196,000 | $276,000 | $229,000 | $159,000 | $128,000 |
| Free cash flow | $332,000 | -$1.1M | -$2.4M | -$1.6M | -$414,000 |
| Share repurchases | $300,000 | — | $27,000 | $3.0M | — |
| Impairments | — | — | — | — | $88,000 |
| Total assets | $53.0M | $62.2M | $53.7M | $56.7M | $32.2M |
| Total liabilities | $4.9M | $6.3M | $4.9M | $8.7M | $6.2M |
Shares outstanding 16.5M · Free float 84.0%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.